First Time Loading...

Theravance Biopharma Inc
NASDAQ:TBPH

Watchlist Manager
Theravance Biopharma Inc Logo
Theravance Biopharma Inc
NASDAQ:TBPH
Watchlist
Price: 9.38 USD -0.95% Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

382m
-8%
Assets
Growth Rates:
1 Year
-37%
3 Years
-19%
5 Years
-32%
7 Years
-40%
10 Years
+1 416%
169m
+0.9%
Liabilities
Growth Rates:
1 Year
+2%
3 Years
-78%
5 Years
-72%
7 Years
-42%
10 Years
+300%
213m
-13%
Equity
Growth Rates:
1 Year
-52%
3 Years
-
5 Years
-
7 Years
-39%
10 Years
-

Balance Sheet Decomposition
Theravance Biopharma Inc

382m
Assets
169m
Liabilities
382m
Assets
169m
Liabilities
Current Assets 133.5m
Cash & Short-Term Investments 165.3m
Receivables 17.5m
Other Current Assets -49.2m
Non-Current Assets 248.5m
PP&E 45.4m
Other Non-Current Assets 203.1m
Current Liabilities 24.8m
Accounts Payable 1.5m
Accrued Liabilities 16.8m
Other Current Liabilities 6.5m
Non-Current Liabilities 144.2m
Other Non-Current Liabilities 144.2m

Balance Sheet
Theravance Biopharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
89
113
345
89
378
58
82
90
298
102
Cash Equivalents
89
113
345
89
378
58
82
90
298
102
Short-Term Investments
165
60
156
260
127
223
212
84
29
63
Total Receivables
2
37
10
9
11
51
70
58
17
17
Accounts Receivables
2
37
10
9
11
12
16
14
17
17
Other Receivables
0
0
0
0
0
39
54
44
0
0
Inventory
13
10
12
17
0
0
0
0
0
0
Other Current Assets
6
18
6
4
17
7
31
19
9
14
Total Current Assets
275
238
529
379
533
339
393
250
354
134
PP&E Net
10
10
9
10
13
59
60
53
52
45
PP&E Gross
10
10
9
10
13
59
60
53
52
45
Accumulated Depreciation
55
42
44
47
50
48
46
39
33
22
Note Receivable
0
0
0
8
0
4
0
0
0
0
Long-Term Investments
51
51
100
42
12
5
13
68
0
0
Other Long-Term Assets
1
2
3
3
2
2
3
4
202
203
Total Assets
338
N/A
300
-11%
639
+113%
441
-31%
560
+27%
409
-27%
469
+15%
375
-20%
607
+62%
382
-37%
Liabilities
Accounts Payable
10
19
2
6
9
5
7
3
2
2
Accrued Liabilities
31
31
47
57
46
66
86
39
27
17
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
10
19
17
0
0
Other Current Liabilities
0
0
0
0
43
32
12
0
0
6
Total Current Liabilities
41
50
49
63
99
112
124
59
29
25
Long-Term Debt
0
0
223
224
454
445
600
599
0
0
Other Liabilities
7
8
17
40
59
76
49
55
137
144
Total Liabilities
48
N/A
57
+19%
289
+406%
326
+13%
612
+88%
633
+3%
773
+22%
713
-8%
166
-77%
169
+2%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
139
322
512
798
1 012
1 249
1 527
1 726
854
909
Additional Paid In Capital
429
565
863
914
961
1 025
1 223
1 388
1 296
1 122
Other Equity
0
0
0
1
0
0
0
0
0
0
Total Equity
290
N/A
243
-16%
350
+44%
115
-67%
52
N/A
224
-334%
304
-36%
339
-11%
442
N/A
213
-52%
Total Liabilities & Equity
338
N/A
300
-11%
639
+113%
441
-31%
560
+27%
409
-27%
469
+15%
375
-20%
607
+62%
382
-37%
Shares Outstanding
Common Shares Outstanding
32
38
53
54
56
57
64
74
65
48

See Also

Summary
TBPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
TBPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TBPH stock valuation using valuation multiples.
Wall Street Estimates
TBPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TBPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.